Syncell logo

Syncell

Syncell is a life science technology company providing unique solutions to next-generation proteomics, unbiased, deep, spatially precise, highly sensitive, and highly specific all in one. Established in 2020, Syncell quickly launched its first Microscoop® platform Microscoop Mint and proprietary reagents Synlight™ and Synpull™ in 2024 to fill the gap of high-precision microscopy-guided proteomic discovery. The technology was designed to address the pain points of biological researchers in breadth, enabling microscopy-guided spatial protein purification and proteomic discovery at any visually recognizable regions of interest. Our commercial team is working tightly with the customers, and together with the R&D and production teams to maximize our customer’s success in discovering key protein players for specific problems of interest. 

Content by Syncell

3D illustration of ciliated cells, with cilia shown in blue.
Fluorescent Imaging of cancer cells growing in 2D with nuclei in blue, cytoplasm in red and DNA damage foci in green.
Syncell’s Microscoop Mint has identified proteins uniquely localized at the peridroplet mitochondrial interface, a region critical for mitochondrial function in non-alcoholic fatty liver disease.
| 4 min read
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue